Health Care

Telemedicine- Just A Fancy Word For Plain Old Medicine?

October 24, 2016

Although “telemedicine” is not some new type of medical breakthrough but rather a vehicle for the delivery of “medicine”, its wide-spread use in delivering medical care in many different scenarios can get bogged down by serious regulatory issues such as: the lack of medical license reciprocity among the states (notwithstanding an increasing number of states adopting the Federation of State Medical Boards Interstate Medical Licensure Compact); the type of informed consent that needs to be given before care is rendered via telemedicine; differing opinions from state-to-state about the standards of care specific to medical care delivered via “telemedicine”; inefficient availability of patient’s medical records and the privacy of those records from state-to-state; requirements for certificates of need in some states to practice even basic forms of medicine; even the types of entities that can legally employ doctors varies among the states.  A high profile example of the challenge of standard of care issue’s confronting medical boards is well documented in the high-profile Texas  cases involving Teladoc. But numerous other states are having their own challenges that are not much different from Texas.  For example, Ohio  and Arkansashave had their own challenges. Even in the absence of these regulatory issues in some states, you still have the fact that health insurers’ payment for telemedicine services currently amounts to less than 1 percent of all of the reimbursements paid to health care providers and health care facilities, although there is some movement on these fronts too. While the promise of telemedicine technology as a form of connecting providers with their patients continues to innovate exponentially, adoption is way behind innovation.  The hot topic for the past several years that garners the most news coverage is “convenience care”, but that is just one aspect of the true value that telemedicine can bring to the table in the delivery of medical care.  Read More

A New Era of Laboratory Fraud Explained in Compliance Today

September 2, 2016

PHILADELPHIA, PA – Marc Stephen Raspanti, Pamela Coyle Brecht and Douglas E. Roberts, attorneys at the law firm Pietragallo Gordon Alfano Bosick & Raspanti, LLP, authored an article titled, “A New Era of Laboratory Fraud, Part 1: Operation LabScam Redux,” that was published in the September 2016 edition of Health Care Compliance Association’s Compliance Today. Part 2 of this article will be featured in the October issue. An early 1990s government investigation called, “Operation LabScam” returned more than $800 million to the government from clinical laboratories that had billed Medicare and other government healthcare programs for medically unnecessary tests, upcoded tests, and tests that were never conducted and provided kickbacks to physicians who referred patients for the illegal testing.  This investigation was supposed to reform the laboratory industry, but now new cases of lab-based fraud and abuse have emerged. Presently, Biodiagnostics Laboratory Services, Inc. was caught participating in a massive scam orchestrated over a seven-year period that involved bribing doctors in three states to refer patients to the lab for medically unnecessary tests. The scam resulted in a mass prosecution of laboratory executives, associates and physicians. The fines handed out to labs are some of the largest settlements ever recovered under the False Claims Act. Pietragallo is one of the nations most experienced and respected law firms handling complex qui tam actions brought under the both the federal and the state false claims acts. Mr. Raspanti, a name partner at the firm, is recognized as one of the most successful, skilled and experienced qui tam attorneys in the United States. He has served as lead counsel for whistleblowers in false claims cases that have resulted in over $2 billion in recoveries for federal and state taxpayers. Ms, Brecht, a partner, is a vibrant member of the Qui Tam Practice Group and litigates some of the most complex Qui Tam cases filed in the United States.  Read More

PICPA Health Care Conference

June 14, 2016

Michael A. Morse will give an update on “Health Care Fraud and Abuse” at the PICPA (Pennsylvania Institute of Certified Public Accountants) Health Care Conference on June 14, 2016.  The event takes place at the Wyndham Gettysburg in Gettysburg, PA. Read More

Pamela Coyle Brecht to Speak at South Carolina Bar Health Care Law Seminar

April 26, 2016

PHILADELPHIA, PA – Pamela Coyle Brecht, partner at the law firm Pietragallo Gordon Alfano Bosick & Raspanti, LLP, will speak at the “False Claims Act/Qui Tam Whistleblower Litigation Involving Health Care Providers” seminar at the South Carolina Bar Conference Center in Columbia, SC on Friday, May 6, 2016. She will be accompanied by esteemed local and national panelists. Ms. Brecht will present on “Private Causes of Action Accompanying FCA Qui Tam Cases”and will also be part of a panel discussion on “Hot Topics from the Plaintiff’s Perspective.” The seminar will focus on federal False Claims Act litigation and the health care industry.  It’s designed to inform attendees on emerging issues arising out of False Claims Act lawsuits involving the clinical health care industry including hospitals, hospices, pharmaceuticals, ambulance companies and laboratories. The program is hosted by the South Carolina Bar Health Care Law Section, South Carolina Bar CLE Division and the South Carolina Federal Bar Association Qui Tam Section. Ms. Brecht is a vibrant member of the Qui Tam Practice Group at Pietragallo. She is also experienced in employment law, internal investigations, white collar criminal litigation, and complex health care litigation. She litigates some of the most complex Qui Tam cases filed in the United States. Her cases have included alleged fraud by a large multi-state Medicaid managed care contractor, FCA violations by three of the largest hospital corporations in the country, and complex financial relationships among healthcare providers, clinical laboratories as well as myriad pharmaceutical fraud. Ms. Brecht is a 1988, cum laude, graduate of Villanova University and a 1991 graduate of Temple University School of Law. While attending Temple University School of Law, Ms. Brecht served as a member of the Temple Law Review and received honors for Distinguished Class Performance. Ms. Brecht is a member of the Philadelphia Bar Association, the American Health Lawyers Association, the Health Care Compliance Association, and the Federal Bar Association Qui Tam Section. Read More

Marc Stephen Raspanti to Speak at the South Carolina Bar Health Care Law Seminar

April 26, 2016

PHILADELPHIA, PA – Marc Stephen Raspanti, partner at the law firm Pietragallo Gordon Alfano Bosick & Raspanti, LLP, will speak at the “False Claims Act/Qui Tam Whistleblower Litigation Involving Health Care Providers” seminar at the South Carolina Bar Conference Center in Columbia, SC on Friday, May 6, 2016. Mr. Raspanti will present on “False Claims Act Pleadings & Related Issues” and will also be a part of a panel discussion on “Hot Topics from the Plaintiff’s Perspective.”  The seminar will focus on federal False Claims Act litigation and the health care industry. It’s designed to inform attendees on emerging issues arising in the context of False Claims Act lawsuits involving health care industries including hospitals, hospices, pharmaceuticals, ambulance companies and laboratories. The program is hosted by the South Carolina Bar Health Care Law Section, South Carolina Bar CLE Division and the South Carolina Federal Bar Association Qui Tam Section. Mr. Raspanti, who is a former prosecutor, is recognized as one of the most successful, skilled and experienced qui tam attorneys in the United States. Since 1989, Mr. Raspanti has litigated many of the most complex and important cases in the history of the federal False Claims Act. He has served as lead counsel for whistleblowers in false claims cases that have resulted in over $2 billion in recoveries for federal and state taxpayers. He practices in the areas of federal and state qui tam litigation, federal and state white collar litigation; criminal and civil health care fraud defense; and complex commercial litigation. Mr. Raspanti received his B.A. from Villanova University in 1979 and his J.D. from Temple University School of Law in 1984.  Mr. Raspanti was selected by his peers as one of Pennsylvania’s Super Lawyers from 2004 through 2015 in the field of White Collar Criminal Defense, an honor reserved for 5% of the Pennsylvania Bar. Read More

PA Bar 22nd Annual Health Law Institute

2016/03/15

Marc S. Raspanti will present “So You Want to Represent a Whistleblower: What Do you Need to Know to Succeed” regarding the ethics of representing whistleblowers, at the Pennsylvania Bar Institutes’ 22nd Annual Health Law Institute in Philadelphia. Read More

Michael A. Morse to Present at the 20th Annual Compliance Institute

March 7, 2016

PHILADELPHIA, PA – Michael A. Morse, partner at the law firm Pietragallo Gordon Alfano Bosick & Raspanti, LLP, will present at the 20th Annual Compliance Institute in Las Vegas, NV.  He will discuss “False Claims Act Developments” at 9:00 am on Sunday, April 17, 2016. The 2016 Compliance Institute, presented by the Health Care Compliance Association (HCCA), will take place from April 17-20 at the Aria Resort and Casino in Las Vegas, NV.  Mr. Morse will be part of a panel discussing the fundamentals of the False Claim Act’s liability, damages, procedures, and whistleblower provisions from the viewpoint of the compliance official. They will also discuss whistleblower, government and defense perspectives on the filing, investigation, litigation and settlement of qui tam cases. As an attendee at the Compliance Institute, you will be attaining knowledge from the most comprehensive conference for today’s healthcare compliance professional. Mr. Morse serves as Chair of the Qui Tam Practice Group and also is a member of the Government Enforcement, Compliance, and White Collar Litigation Group as well as the Health Care and Litigation Practice Groups at Pietragallo. He is a former prosecutor who has developed a nationwide practice representing whistleblowers under federal and state false claims acts.  Mr. Morse has served as counsel for the lead whistleblowers in a number of the most successful false claims cases in United States history, resulting in hundreds of millions of dollars in recoveries for federal and state taxpayers. Mr. Morse currently serves as the Co-Chair of the Philadelphia Bar Association’s Federal Courts Committee. He has been selected as a Pennsylvania Super Lawyer for 2013, 2014, and 2015 in the area of White Collar Criminal Defense.  Mr. Morse received his B.A. from the University of Michigan and his J.D. from Emory University Law School. For more information regarding the upcoming Health Care Compliance Institute or to register, please visit http://www.compliance-institute.org/. Read More

Pamela Coyle Brecht to Present at the 20th Annual Compliance Institute

March 7, 2016

PHILADELPHIA, PA – Pamela Coyle Brecht, partner at the law firm Pietragallo Gordon Alfano Bosick & Raspanti, LLP, will present at the 20th Annual Compliance Institute in Las Vegas, NV. She will speak on “Managed Care Fraud: Enforcement and Compliance” on Tuesday, April 19, 2016 at 11:00 am. The four-day event takes place from April 17-20 at the Aria Resort and Casino in Las Vegas, NV.  The 2016 Compliance Institute, presented by the Health Care Compliance Association (HCCA), will help attendees better understand the chaos of healthcare reform, hospital physician alignment, compliance effectiveness, and HIPAA Privacy/Data Breach; which are adding complexity to the regulatory compliance challenges facing healthcare professionals today. Professionals such as healthcare specialists, risk managers, attorneys, regulators, physicians and more will learn how recent laws, regulations, and enforcement actions will affect compliance programs. Ms. Brecht is an active member of the Qui Tam Practice Group at Pietragallo. She is also experienced in employment law, internal investigations, white collar criminal litigation, and complex health care litigation. She litigates some of the most complex Qui Tam cases filed in the United States. Her cases have included alleged fraud by a large multi-state Medicaid managed care contractor, FCA violations by three of the largest hospital corporations in the country, and complex financial relationships among healthcare providers, as well as pharmaceutical fraud. She is also part of the team that is advancing one of the first national cases alleging fraud against the Medicare Part D program. Ms. Brecht is a 1988, cum laude, graduate of Villanova University and a 1991 graduate of Temple University School of Law. While attending Temple University School of Law, Ms. Brecht served as a member of the Temple Law Review and received honors for Distinguished Class Performance. Ms. Brecht is a member of the Philadelphia Bar Association, the American Health Lawyers Association, the Health Care Compliance Association, the Federal Bar Association Qui Tam Section, the Brehon Law Society, and the Justinian Law Society. Read More

News & Events

Related News

23 Pietragallo Lawyers Named in 2026 The Best Lawyers In America and Ones to Watch
August 21, 2025
Pietragallo Gordon Alfano Bosick & Raspanti, LLP is pleased to announce that 23 lawyers have been named as 2026 The Best Lawyers in America® and Ones to Watch. Read More
Chambers USA Recognizes Pietragallo as a 2025 Leading Law Firm in Pennsylvania
June 5, 2025
Pietragallo Gordon Alfano Bosick & Raspanti, LLP has been recognized by Chambers and Partners USA in its 2025 Guide in the areas of False Claims Act in USA-Nationwide (Band 2), White Collar Crime & Government Investigations in Pennsylvania (Band 2), and General Commercial in Pennsylvania: Pittsburgh & Surrounds (Band 3). Read More

Upcoming Events

Pamela Coyle Brecht and Marc S. Raspanti to Present Discovery in FCA Litigation
May 11, 2026
On May 11, 2026, partners Pamela Coyle Brecht and Marc S. Raspanti will be presenting “Discovery in FCA Litigation: Building Bridges to and Avoiding Pitfalls,” hosted on myLawCLE, an opportunity made possible through the firm’s sponsorship of the Federal Bar Association’s 2026 Qui Tam Conference. Read More
View More News & Events